Benzinga's Top Pre-Market Gainers
Supernus Pharmaceuticals (NASDAQ: SUPN) moved up 26.51% to $8.40 in the pre-market session after the company received final approval from the FDA for Trokendi XR.
Partner Communications Company (NASDAQ: PTNR) soared 3.75% to $8.02 in the pre-market trading. Partner Communications is expected to report its reviewed financial results for the second quarter on August 28, 2013.
Chesapeake Energy (NYSE: CHK) surged 3% to $25.75 in the pre-market session after Carl Icahn lifted his stake in Chesapeake to 9.98% from 8.98%.
MannKind (NASDAQ: MNKD) shares gained 2.77% to $5.93 in the pre-market session. MannKind's PEG ratio is 0.06.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.